Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
NBF-006 by Nitto BioPharma for Metastatic Pancreatic Cancer: Likelihood of Approval
NBF-006 is under clinical development by Nitto BioPharma and currently in Phase I for Metastatic Pancreatic Cancer. According to GlobalData,...
Data Insights
NBF-006 by Nitto BioPharma for Metastatic Colorectal Cancer: Likelihood of Approval
NBF-006 is under clinical development by Nitto BioPharma and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData,...